Leucadia National Corporation »

Crispr Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 25k 63.00
2022-12-31 $783k 19k 40.65